Art

J-GLOBAL ID：201702265676480974   Reference number：17A0001868

Case Report of a Patient with Drug-Induced Thrombocytopenia Related to Readministration after Discontinuation due to Allergy to Oxaliplatin

オキサリプラチンによるアレルギーで中止後,再投与により薬剤誘発性血小板減少症に至った1症例

Author (10)： HONDA SHINJI (京都市病院 薬剤科) ,  MURATA TATSUNORI (京都市病院 薬剤科) ,  MIMATSU SHINO (京都市病院 薬剤科) ,  SABURI MIHOKO (京都市病院 薬剤科) ,  KUSUKAWA YUGO (京都市病院 薬剤科) ,  MEGURO YUJI (京都市病院 薬剤科) ,  ONO KEIICHI (京都市病院 薬剤科) ,  ITO TETSUO (京都市病院 消化器外科) ,  KATSURA TOSHIYA (立命館大 薬) ,  MURAOKA JUNJI (京都市病院 薬剤科)
Material： 医療薬学  (Japanese Journal of Pharmaceutical Health Care and Sciences)
Volume： 42  Issue： 12  Page： 834-838  Publication year： Dec. 10, 2016 
JST Material Number： Y0888A  ISSN： 1346-342X  CODEN： IYRAA3  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Cancer of sigmoid colon ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0001868&from=J-GLOBAL&jstjournalNo=Y0888A") }}

JST classification (4)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Immunologic diseases,allergic diseases in general.  (GD04010C)

Substance index (4)： Levoleucovorin ,  Fluorouracil ,  Methylprednisolone ,  Nafamostat mesilate

Reference (17)：

• 1)Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzen F, Noh SH, CLASSIC trial investigators, Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial, Lancet, 2012, 379, 315-321.
• 2)Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ, CLASSIC trial investigators, Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial, Lancet Oncol, 2014, 15, 1389-1396.
• 3)Suh SE, Jang MJ, Chong SY, Aster RH, Curtis BR, Oh D, A case of oxaliplatin-induced immune-mediated thrombocytopenia, Blood Res, 2014, 49, 61-64.
• 4)Mittal K, McNamara MJ, Curtis BR, McCrae KR, Antiplatelet antibodies in oxaliplatin-induced immune thrombocytopenia, JRSM Open, 2014, 5, doi: 10.1177/2054270414531126.
• 5)Woo HS, Lee KH, Yoon PH, Kim SJ, Park I, Kim YS, Ahn HK, Hong J, Shin DB, Sym SJ, Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report, Cancer Res Treat, 2015, 47, 949-953.

Terms in the title (7)： オキサリプラチン ,  アレルギー ,  中止 ,  再投与 ,  薬剤 ,  血小板減少症 ,  症例